Cytek Biosciences
CTKB
CTKB
106 hedge funds and large institutions have $428M invested in Cytek Biosciences in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.02% less ownership
Funds ownership: 56.78% → 56.77% (-0.02%)
35% less capital invested
Capital invested by funds: $658M → $428M (-$230M)
Holders
106
Holding in Top 10
–
Calls
$344K
Puts
$57K
Top Buyers
| 1 | +$15.6M | |
| 2 | +$9.07M | |
| 3 | +$3.87M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.55M |
Top Sellers
| 1 | -$30.3M | |
| 2 | -$10.7M | |
| 3 | -$3.25M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.58M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.28M |